Davies Thomas G., et al. “Pyramid: An integrated platform for fragment-based drug discovery.” Fragment-based approaches in drug discovery: Volume 34, Chapter 10, pp 193-214. Edited by W Jahnke and D. A. Erlanson. WILEY-VCG Verlag GmbH & Co. KGaA, Weinheim 2007. ISBN: 978-3-527-31291-7.

/in ,

Davies Thomas G., et al. “Pyramid: An integrated platform for fragment-based drug discovery.” Fragment-based approaches in drug discovery: Volume 34, Chapter 10, pp 193-214. Edited by W Jahnke and D. A. Erlanson. WILEY-VCG Verlag GmbH & Co. KGaA, Weinheim 2007. ISBN: 978-3-527-31291-7.

Howard, N., et al. “Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors.” Journal of Medicinal Chemistry 49, no. 4 2006: 1346–1355. DOI: 10.1021/jm050850v.

/in ,

Howard, N., et al. “Application of Fragment Screening and Fragment Linking to the Discovery of Novel Thrombin Inhibitors.” Journal of Medicinal Chemistry 49, no. 4 2006: 1346–1355. DOI: 10.1021/jm050850v.

Mooij W. T. M. et al. “Automated Protein–Ligand Crystallography for Structure-Based Drug Design.” ChemMedChem 1, no. 8 2006: 827–838. DOI: 10.1002/cmdc.200600074.

/in ,

Mooij W. T. M. et al. “Automated Protein–Ligand Crystallography for Structure-Based Drug Design.” ChemMedChem 1, no. 8 2006: 827–838. DOI: 10.1002/cmdc.200600074.

Murray C. W., Verdonk et al. “Entropic consequences of linking ligands.” Fragment-based approaches in drug discovery: Volume 34, Chapter 3, pp 55-66. Edited by W Jahnke and D. A. Erlanson. WILEY-VCG Verlag GmbH & Co. KGaA, Weinheim 2006. ISBN: 978-3-527-31291-7.

/in ,

Murray C. W., Verdonk et al. “Entropic consequences of linking ligands.” Fragment-based approaches in drug discovery: Volume 34, Chapter 3, pp 55-66. Edited by W Jahnke and D. A. Erlanson. WILEY-VCG Verlag GmbH & Co. KGaA, Weinheim 2006. ISBN: 978-3-527-31291-7.